Daewoong (003090) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Daewoong (003090) has a cash flow conversion efficiency ratio of 0.052x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩84.83 Billion ≈ $57.49 Million USD) by net assets (₩1.63 Trillion ≈ $1.10 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Daewoong - Cash Flow Conversion Efficiency Trend (2001–2024)
This chart illustrates how Daewoong's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Daewoong for a breakdown of total debt and financial obligations.
Daewoong Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Daewoong ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shanghai Metersbonwe Fashion&Accessories Co Ltd
SHE:002269
|
-0.591x |
|
Zhongrui Co Ltd
SHE:301587
|
0.017x |
|
RaySearch Laboratories AB (publ)
ST:RAY-B
|
-0.013x |
|
S.J.S. Enterprises Limited
NSE:SJS
|
0.028x |
|
Anhui Zhonghuan Environmental Protection Technology Co Ltd
SHE:300692
|
0.028x |
|
Guangbo Group Stock Co Ltd
SHE:002103
|
0.121x |
|
Hindustan Construction Company Limited
NSE:HCC
|
0.123x |
|
AMN Healthcare Services Inc
NYSE:AMN
|
0.035x |
Annual Cash Flow Conversion Efficiency for Daewoong (2001–2024)
The table below shows the annual cash flow conversion efficiency of Daewoong from 2001 to 2024. For the full company profile with market capitalisation and key ratios, see Daewoong (003090) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩1.50 Trillion ≈ $1.02 Billion |
₩162.38 Billion ≈ $110.05 Million |
0.108x | -24.49% |
| 2023-12-31 | ₩1.44 Trillion ≈ $973.70 Million |
₩205.65 Billion ≈ $139.37 Million |
0.143x | +22.84% |
| 2022-12-31 | ₩1.28 Trillion ≈ $867.10 Million |
₩149.08 Billion ≈ $101.03 Million |
0.117x | +1.23% |
| 2021-12-31 | ₩1.16 Trillion ≈ $784.11 Million |
₩133.18 Billion ≈ $90.25 Million |
0.115x | -11.56% |
| 2020-12-31 | ₩1.12 Trillion ≈ $756.92 Million |
₩145.37 Billion ≈ $98.51 Million |
0.130x | -3.57% |
| 2019-12-31 | ₩1.03 Trillion ≈ $695.47 Million |
₩138.51 Billion ≈ $93.87 Million |
0.135x | +186.80% |
| 2018-12-31 | ₩964.31 Billion ≈ $653.50 Million |
₩45.38 Billion ≈ $30.75 Million |
0.047x | -70.09% |
| 2017-12-31 | ₩939.31 Billion ≈ $636.55 Million |
₩147.77 Billion ≈ $100.14 Million |
0.157x | +625.25% |
| 2016-12-31 | ₩864.63 Billion ≈ $585.95 Million |
₩18.76 Billion ≈ $12.71 Million |
0.022x | -76.01% |
| 2015-12-31 | ₩828.48 Billion ≈ $561.45 Million |
₩74.92 Billion ≈ $50.77 Million |
0.090x | +37.51% |
| 2014-12-31 | ₩708.73 Billion ≈ $480.30 Million |
₩46.61 Billion ≈ $31.59 Million |
0.066x | -47.58% |
| 2013-12-31 | ₩687.07 Billion ≈ $465.62 Million |
₩86.19 Billion ≈ $58.41 Million |
0.125x | +77.80% |
| 2012-12-31 | ₩391.40 Billion ≈ $265.24 Million |
₩27.62 Billion ≈ $18.71 Million |
0.071x | +127.92% |
| 2011-12-31 | ₩336.10 Billion ≈ $227.77 Million |
₩10.40 Billion ≈ $7.05 Million |
0.031x | -56.40% |
| 2010-12-31 | ₩484.70 Billion ≈ $328.47 Million |
₩34.42 Billion ≈ $23.32 Million |
0.071x | -74.17% |
| 2009-12-31 | ₩429.38 Billion ≈ $290.98 Million |
₩118.04 Billion ≈ $79.99 Million |
0.275x | +99.96% |
| 2008-12-31 | ₩412.53 Billion ≈ $279.57 Million |
₩56.71 Billion ≈ $38.43 Million |
0.137x | +19.93% |
| 2007-12-31 | ₩363.46 Billion ≈ $246.31 Million |
₩41.66 Billion ≈ $28.23 Million |
0.115x | -35.45% |
| 2006-12-31 | ₩294.16 Billion ≈ $199.35 Million |
₩52.24 Billion ≈ $35.40 Million |
0.178x | +16.42% |
| 2005-12-31 | ₩251.13 Billion ≈ $170.19 Million |
₩38.30 Billion ≈ $25.96 Million |
0.153x | -3.90% |
| 2004-12-31 | ₩222.67 Billion ≈ $150.90 Million |
₩35.34 Billion ≈ $23.95 Million |
0.159x | +3.01% |
| 2003-12-31 | ₩213.98 Billion ≈ $145.01 Million |
₩32.97 Billion ≈ $22.34 Million |
0.154x | -1.38% |
| 2002-12-31 | ₩205.55 Billion ≈ $139.30 Million |
₩32.11 Billion ≈ $21.76 Million |
0.156x | -43.51% |
| 2001-12-31 | ₩228.75 Billion ≈ $155.02 Million |
₩63.26 Billion ≈ $42.87 Million |
0.277x | -- |
About Daewoong
Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea. It is also involved in the real estate rental business; provision of lifestyle-related disease prevention research, business management, public affairs, and facility management services; and processing and sale of food products. The company was formerly known as Daewoong Phar… Read more